[1] Royal Marsden NHS Fdn Trust, Gynaecol Unit, London, England
[2] Inst Canc Res, London, England
[3] Univ Lausanne, Lausanne Univ Hosp, Dept Oncol, Lausanne, Switzerland
[4] Univ Glasgow, Med Oncol, Beatson West Scotland Canc Ctr, Glasgow, Scotland
[5] Univ Glasgow, Inst Canc Sci, Glasgow, Scotland
[6] Seoul Natl Univ Hosp, Dept Obstet & Gynaecol, Seoul, South Korea
[7] Yonsei Univ, Div Med Oncol, Dept Internal Med, Yonsei Canc Ctr,Coll Med, Seoul, South Korea
[8] Newcastle Upon Tyne Hosp NHS Fdn Trust, Northern Ctr Canc Care, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England
[9] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England
[10] Rabin Med Ctr, Davidoff Ctr, Beilinson Campus, Petah Tiqwa, Israel
[11] Univ Claude Bernard Lyon 1, Univ Lyon, Inst Cancerol Hosp Civils Lyon IC HCL, Serv Oncol Med,CITOHL,GINECO, Pierre Benite, France
[12] NHS Tayside, Ninewells Hosp, Dept Oncol, Dundee, Scotland
[13] Massachusetts Gen Hosp, Div Haematol Oncol, Boston, MA USA
[14] Ohio State Univ, Div Gynaecol Oncol, James Comprehens Canc Ctr, Columbus, OH USA
[15] AstraZeneca, Late Dev Oncol, Oncol R&D, Gaithersburg, MD USA
[16] AstraZeneca, Late Oncol Stat, Oncol R&D, Cambridge, England
[17] AstraZeneca, Translat Med, Oncol R&D, Cambridge, England
[18] AstraZeneca, Immuno Oncol, Late Phase R&D, Gaithersburg, MD USA
[19] Univ Penn, Basser Ctr BRCA, Philadelphia, PA USA